Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    "pachyonychia congenita" OR "Keratoderma, Palmoplantar"
Show Display Options
Rank Status Study
1 Completed
Has Results
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
Condition: Pachyonychia Congenita
Intervention: Drug: 1% sirolimus cream (TD201 1%)
2 Completed Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Interventions: Drug: TD101;   Drug: Normal saline (placebo)
3 Unknown  Simvastatin Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Intervention: Drug: Simvastatine
4 Recruiting International Pachyonychia Congenita Research Registry
Condition: Pachyonychia Congenita
Intervention:
5 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
6 Recruiting Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Conditions: Epidermolysis Bullosa Simplex;   Pachyonychia Congenita
Interventions: Drug: Jojoba oil with broccoli sprout extract;   Drug: Jojoba oil (placebo)
7 Completed The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
Conditions: Basal Cell Carcinoma;   Keratosis Palmaris et Plantaris;   Psoriasis
Intervention:
8 Completed
Has Results
Cytokines in Papillon-Lefèvre Syndrome
Condition: Papillon-Lefevre Disease
Intervention:

Study has passed its completion date and status has not been verified in more than two years.